Press Releases

First patient in Phase I/II clinical trial expected to be enrolled in Q4 2025 UK Clinical Trial Application (CTA) approval shortly follows U.S. IND clearance…

PS-002, Purespring’s lead precision nephrology programme, targets the complement pathway known to be a driver of IgA nephropathy IND clearance follows the granting of European…

Haseeb Ahmad brings over 25 years of leadership experience in life sciences, most recently serving as President of Novartis Europe and will lead the Company…

Oversubscribed financing led by Sofinnova Partners in collaboration with Gilde Healthcare, Forbion, British Patient Capital and founding investor Syncona Funds raised will support Purespring in…

Appointments of Fredrik and Peter complete build-out of senior team. London— 6 September 2023 Purespring Therapeutics, a pioneering gene therapy company focused on transforming the…

Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, announces the appointments of Dr Ronny Renfurm as Chief Medical…

FunSel is Purespring’s proprietary in-vivo ‘gene search engine’, which allows functional selection of therapeutic factors unconstrained by previous drug discovery bias SwanBio will use FunSel…

Syncona Ltd, a leading healthcare company focused on founding, building and funding a portfolio of global leaders in life science, announces the foundation of a…